HepaHope —We Deliver A Better Life
HepaHope develops and commercializes therapeutic and diagnostic technologies to improve patient health.
We strive to improve the quality of life and life expectancy of liver failure patients with our Bio-Artificial Liver device.
We aim to create a new paradigm shift in diagnostics.
HepaHope News
- 2.24.11 - The City of Hope Medical Research Center has signed an agreement to provide HepaHope with a variety of malignant human tumor tissue samples in a joint project to evaluate the potential of HepaHope's Chemosensitivity Testing device for use in personalized medicine.
- 2.16.11 -HepaHope received an acknowledgement letter from the USDA APHIS advising that the company had passed its inspection and is in compliance with the Animal Welfare Act, regulations and standards.
- 02.08.11 - As a result of receiving no USDA inspection observations, HepaHope was notified that a USDA dealer's license to sell its Veterinary application of the HepaPheresis™ treatment was approved.